Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (51-60 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|August 6, 2016
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinomaYu You, Jia-Xin Tan, Hai-Su Dai, et al.
Oncotarget|August 6, 2016
Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1Kaikai Shen, Zhichao Xi, Jianling Xie, et al.
Oncotarget|August 6, 2016
Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancerHonghong Shen, Lin Zhao, Xiaolong Feng, et al.
Oncotarget|August 6, 2016
Novel antibody probes for the characterization of endosialin/TEM-1Daniel J O'Shannessy, Michael F Smith, Elizabeth B Somers, et al.
Oncotarget|August 6, 2016
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinomaYeonjung Ha, Danbi Lee, Ju Hyun Shim, et al.
Oncotarget|August 6, 2016
Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activityXiulong Xu, Geetha Rao, Yi Li
Oncotarget|August 6, 2016
Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomideBirgit C Weyhenmeyer, Janis Noonan, Maximilian L Würstle, et al.
Oncotarget|August 6, 2016
Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patientsShijie Liu, Zuhong Tian, Lei Zhang, et al.
Oncotarget|August 6, 2016
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphomaEugenio Gaudio, Chiara Tarantelli, Maurilio Ponzoni, et al.
Oncotarget|August 6, 2016
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemiaAyman A M Alameen, Carolina Simioni, Alberto M Martelli, et al.
Pageof 2,673

Showing results (51-60 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|August 6, 2016
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinomaYu You, Jia-Xin Tan, Hai-Su Dai, et al.
Oncotarget|August 6, 2016
Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1Kaikai Shen, Zhichao Xi, Jianling Xie, et al.
Oncotarget|August 6, 2016
Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancerHonghong Shen, Lin Zhao, Xiaolong Feng, et al.
Oncotarget|August 6, 2016
Novel antibody probes for the characterization of endosialin/TEM-1Daniel J O'Shannessy, Michael F Smith, Elizabeth B Somers, et al.
Oncotarget|August 6, 2016
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinomaYeonjung Ha, Danbi Lee, Ju Hyun Shim, et al.
Oncotarget|August 6, 2016
Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activityXiulong Xu, Geetha Rao, Yi Li
Oncotarget|August 6, 2016
Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomideBirgit C Weyhenmeyer, Janis Noonan, Maximilian L Würstle, et al.
Oncotarget|August 6, 2016
Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patientsShijie Liu, Zuhong Tian, Lei Zhang, et al.
Oncotarget|August 6, 2016
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphomaEugenio Gaudio, Chiara Tarantelli, Maurilio Ponzoni, et al.
Oncotarget|August 6, 2016
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemiaAyman A M Alameen, Carolina Simioni, Alberto M Martelli, et al.
Pageof 2,673